Eli Lilly and Company (LLY.SW) News
Follow Eli Lilly and Company (LLY.SW) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
H
RBC Lifts Eli Lilly Price Target on Expected 'Strong' Q2 Performance of Obesity Drugs
() -- RBC Capital Markets expects Eli Lilly (LLY.SW) to report a "strong" performance from obesity drugs Zepbound and Mounjaro when it publishes its second-quarter results on Aug. 5. The US-based pharmaceutical company's
EARNINGS | Jul 08, 2026, 12:09 PM UTC
L
DKSH to Promote, Distribute Eli Lilly's Pharmaceutical Products in Hong Kong, Macau
() -- DKSH (DKSH.SW) said Monday it agreed to market and distribute the products of pharmaceutical giant Eli Lilly (LLY.SW, LLY.F) in Hong Kong and Macau. The distribution-and-promotion agreement covers Lilly's existing
EQUITY | Jul 06, 2026, 05:40 AM UTC